Clinical Trials Browser

Advanced Solid Tumors × Docetaxel × Genitourinary × Clear all

NCT01094288 2019-02-15

A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

Phase 1 Completed

41 enrolled 31 charts

GenitourinaryOther solid neoplasm

Advanced Solid Tumors